Tag: COVID-19
NANETS Issues Position Statement on COVID-19 Vaccination for NET and NEC Patients
February 5, 2021
A growing body of evidence suggests that patients with cancer have an increased risk of severe COVID-19 infection and related complications. As such, NANETS, the North American Neuroendocrine Tumor Society, supports the plan for COVID-19 vaccination…
READ MOREBreaking News: Novartis Temporarily Modifies U.S. Mobile Administration Program for Sandostatin LAR During Pandemic
April 8, 2020
Due to the COVID-19 pandemic and Novartis’ ongoing commitment to support patients, Novartis has temporarily modified the eligibility criteria related to their U.S. mobile administration program (MAP) to allow for use by patients currently receiving…
READ MORE
